Who we are

Who we are

Board of Directors

  • Katy Brodsky Falco comes to this work through an equity lens, having worked in criminal justice reform for 20 years. After surviving both HELLP syndrome and breast cancer, Katy was horrified to learn about the long history of inequities in rigorous research of women’s health. Seeing how clearly the public sector failed to close the gender equity gap in health for decades across both democratic and republican administrations, she created the Foundation for Women’s Health as a private sector solution to not only equalize research funding for diseases across gender, but also across disease. Prior to this work, Katy built and managed non-profit research organizations for leading academic institutions for a decade. She served as Executive Director of NYU School of Law's Criminal Justice Lab and Executive Director of Crime Lab New York, a criminal justice research organization based at University of Chicago. She was also Executive Director of Reentry Services at the NYC Department of Corrections and a staff attorney at Legal Aid Society in the Criminal Defense Division. Katy attended Harvard University for her BA and NYU School of Law for her JD.

  • Dr. Orli Etingin is the Lisa and Sanford B. Ehrenkranz Professor of Clinical Medicine at Weill Cornell Medical College. She served as Vice Chairman of the Department of Medicine at NewYork Presbyterian/Weill Cornell Medical Center from 1997-2009. She is the founder and Medical Director of the Iris Cantor Women's Health Center, a multidisciplinary group practice sponsored by the Departments of Dermatology, Medicine, Obstetrics and Gynecology, Radiology, Surgery, and Urology. Dr. Etingin received her undergraduate degree from Johns Hopkins University and her medical degree from Albert Einstein College of Medicine in New York. She completed her residency training in Internal Medicine, subspecialty training in Hematology-Oncology and her Chief Residency at the New York Hospital-Cornell Medical Center. Dr. Etingin received an NIH Clinical Investigator Award from 1987 until 1992, during which time she conducted laboratory research on thrombosis in vascular cells. Dr. Etingin is a member of the American Medical Women's Association and the American Medical Association. She is the editor of two nationally distributed newsletters, Women's Health Advisor and Food & Fitness Advisor, and a contributor to Everyday Health.

Sabrina Mallick

  • Sabrina Mallick is the Founder of Sunset Ventures, where she serves as an investor, advisor, and operating partner. An active angel investor in more than 30 venture-backed companies, she has focused her portfolio on women-founded brands and companies advancing health and wellness. Before founding Sunset, Sabrina spent nearly a decade as President of a consumer products incubator where she led mass-market brands in food, beverage, and skin care from concept through national retail, overseeing product development, manufacturing, distribution and go-to-market strategy. She began her career at Credit Suisse and Citigroup, where she focused on due diligence, underwriting, institutional fundraising, and capital markets. She earned her B.A. from Princeton University.

Dr. Orli Etingin

Katy Brodsky Falco

Medical Advisory Board

Dr. Amy G. Cantor

Dr. Sara Hurvitz

  • Dr. Narain is Associate Professor of Medicine and Director of Health Services and Health Optimization Research at the Iris Cantor UCLA Women’s Health Center. Her research seeks to illuminate the health equity implications of social, economic and health policy interventions among women, racial/ethnic minorities, and individuals with low socio-economic status. She has examined the impact of Welfare Reform and Earned Income Tax Credit laws on the health outcomes of single mothers and conducted one of the few studies to explore the differential impact of state-level minimum wage laws across race/ethnicity and gender. Furthermore, she conducted one of the first studies to explore the relationship between work structure and risk factors for cardiovascular disease among women. Dr. Narain received dual B.S. degrees in Microbiology and African-American studies from UCLA and an M.D. from Morehouse School of Medicine. She completed her residency in Primary Care Internal Medicine at the University of California, San Francisco, after which she completed a California Endowment Minority Health Policy Fellowship at Harvard Medical School. After leaving Harvard, she completed a Robert Wood Johnson Clinical Scholar Fellowship and earned a PhD in Health Services from the UCLA Fielding School of Public Health.

  • Dr. Regensteiner is the co-founder and director of the Ludeman Family Center for Women’s Health Research, and Distinguished Professor of Medicine in the Divisions of Internal Medicine and Cardiology at the University of Colorado Anschultz Medical Campus. Her research expertise is in the cardiovascular effects of diabetes—with a specific focus on women with type 2 diabetes, seeing as they appear to have more significant cardiovascular abnormalities than men with diabetes. Her lab has been funded for over 30 years, and she has authored more than 180 research publications that have influenced the field. She served on the Advisory Committee for the NIH’s Office of Research on Women’s Health, is an alumna of the Executive Leadership in Academic Medicine Program, and is on the steering committee of the National Leaders in Women’s Health group.

Dr. Janet Pregler

  • Dr. Pregler is the Iris Cantor Endowed Professor in Women's Health at the David Geffen School of Medicine at the University of California, Los Angeles. Dr. Pregler has directed the Iris Cantor-UCLA Women's Health Center since 1997. The UCLA Iris Cantor-UCLA Women's Health Center Executive Advisory Board Pilot Research Program, in collaboration with the UCLA Clinical Translational Science Institute, has funded pilot research in women's health and sex and gender based medicine for 20 years. Dr. Pregler's clinical interests include menopause and primary care of the breast cancer survivor. She has developed educational programs on women’s health for the American College of Physicians, Centers for Disease Control and Prevention, National Heart, Lung, and Blood Institute, and the Department of Health and Human Services, Office on Women’s Health. In 2017, she was recognized as “Woman of the Year” in the health category by the Los Angeles County Commission for Women for her work developing health education programs collaborating with community experts for medically underserved communities, focusing on women's health and environmental toxins, financial literacy, and lesbian, bisexual and queer women's health.

Dr. Marlena Fejzo

Dr. Phyllis August

  • Dr. Fejzo is a faculty researcher in the Center for Genetic Epidemiology at the University of Southern California. She was voted 2023’s Fiercest Woman in Life Sciences as well as one of 2024’s Time Women of the Year and Time100 Health Honorees. She has published papers on her genetic studies of many diseases of women including ovarian cancer, breast cancer, and multiple sclerosis, and she was the first to discover the genetic cause of both uterine fibroids and Hyperemesis Gravidarum. She started to research HG after becoming bedridden during her pregnancy in 1999 and unable to eat for 10 weeks, ultimately losing a baby at 15 weeks gestation to the disease. She also serves on the Board of Directors of the HER Foundation, which promotes awareness, support and research of Hyperemesis Gravidarum.

  • Dr. August is a Professor of Medicine in Obstetrics and Gynecology and Professor of Public Health at Weill Cornell in New York. Dr. August graduated from Harvard College and Yale Medical School and completed her internship at Yale. She received a Masters in Public Health from the Harvard School of Public Health. She is the Director of the Weill Cornell Hypertension Center and is the Program Director for the Nephrology Fellowship at New York Presbyterian-Cornell Campus. She is the Theresa Lang Director of the Lang Center for Research and Education at NewYork-Presbyterian/Queens. Dr. August’s research has focused on blood pressure regulation in pregnancy, hypertension in pregnancy, hypertension associated with kidney disease, and kidney disease associated with pregnancy. Her clinical practice at Weill Cornell is largely devoted to hypertension, kidney disease, and obstetric hypertension and kidney disorders.

Dr. Judy Regensteiner

Dr. Kimberly D. Narain

  • Dr. Hurvitz is a medical oncologist and clinical research leader who is senior vice president of the Clinical Research Division at Fred Hutch and head of the Division of Hematology and Oncology at the University of Washington Department of Medicine. A graduate of the Keck School of Medicine at the University of Southern California, Hurvitz is an international expert in breast oncology and a leader in clinical and laboratory-based oncology research, with extensive experience leading clinical trials in all phases. Dr. Hurvitz works to boost the national reputation of the solid tumor clinical research program and oversees the continued growth of clinical research programs in stem cell transplantation and cell therapy, hematologic cancers and nonmalignant hematology. Dr. Hurvitz has contributed extensively to the growth of clinical research programs since joining the University of California, Los Angeles as a resident in 1999. She is a member of the American College of Physicians, the American Society of Hematology, the American Society of Clinical Oncology, American Association for Cancer Research, the European Society of Medical Oncology and the American College of Physicians.

  • Dr. Cantor is a family physician and Professor of Medicine, Family Medicine and Obstetrics and Gynecology at Oregon Health and Science University (OHSU) who serves as primary care faculty at the OHSU Center for Women’s Health and Senior investigator at the Pacific Northwest Evidence-based Practice center. She has extensive clinical and research expertise in women's health across the lifespan including a master’s degree in public health, fellowship training in women’s health, and certification by the Menopause society. Dr. Cantor is nationally recognized for her leadership in women’s health research and evidence synthesis. She has led and contributed to several systematic evidence reviews that have directly informed national clinical practice guidelines, health policy, and health care coverage decisions affecting millions of Americans. Dr. Cantor has served on influential national committees including the USPSTF, the WPSI Advisory Panel, and as Methods Advisor for the Cochrane Fertility Regulation Review Group. In addition to research, Dr. Cantor serves as the Medical Director of Evidence Based Guidelines for OHSU health.

Dr. Larissa Rodriguez

Dr. Sallie Permar

  • Dr. Rodriguez is Chair of the Department of Urology, Professor of Urology and Obstetrics and Gynecology, and Director of the Division of Female Pelvic Medicine and Reconstructive Surgery/Urogynecology at Weill Cornell Medicine. She has a bachelor’s degree in Mathematics from MIT and completed her medical training and Urology residency at Stanford University and completed her fellowship at UCLA. Dr. Rodriguez’s clinical research focuses on outcomes of vaginal and robotic surgery, quality of life, and health disparities as it relates to pelvic floor disorders, and the pathophysiology and treatment of interstitial cystitis. In the laboratory she is pursuing investigations on the role of environmental stress in the development and maintenance of urinary symptoms, voiding dysfunction and bladder pain. She is an expert in the care of women with pelvic floor disorders including urinary incontinence and voiding dysfunction, pelvic organ prolapse, urinary fistulas and genitourinary tract reconstruction. She has been voted a Southern California Super Doctor, and was the recipient of multiple research awards from the American Urological Association, the Western Section of the AUA, and the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (SUFU). She was also the recipient of the Zimskind Award, an award given by SUFU to an individual with significant contribution to the field of Pelvic Medicine and Voiding Dysfunction within the first 10 years of their career.

  • Dr. Permar is an eminent physician-scientist who focuses on the treatment and prevention of neonatal viral infections. She serves as Chair of the Department of Pediatrics at Weill Cornell Medicine and Pediatrician-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center and New York-Presbyterian Komansky Children’s Hospital, where she helps to expand access to equitable, quality primary and subspecialty care for pediatric patients throughout New York City. She is also the Nancy C. Paduano Professor in Pediatrics at Weill Cornell Medicine and Professor of Immunology and Microbial Pathogenesis at the Weill Cornell Graduate School. A prominent physician-scientist in pediatrics, Dr. Permar’s research focuses on the treatment and prevention of viral infections in newborns. She and her team are working on the development of vaccines to prevent mother-to-child transmission of viruses such as HIV, Zika and cytomegalovirus (CMV)—the most common congenital infection and a leading cause of birth defects, affecting roughly one in 150 newborns. She discovered in her research a protein in breast milk that neutralizes HIV, and developed a non-human primate model for congenital CMV infection, now being used to test CMV vaccine strategies.

Dr. Emily Jacobs

Dr. Gayatri Devi

  • Dr. Jacobs is Professor of Neuroscience at UC Santa Barbara and Director of the Ann S. Bowers Women's Brain Health Initiative. Her body of research is redefining our understanding of the brain’s capacity to undergo dynamic neuroanatomical changes and plasticity well into adulthood. In 2024, her team published the first detailed map of the human brain across pregnancy and she leads several multi-center studies on neurological changes tied to menopause. Dr. Jacobs serves on the Steering Committee of the Coalition for Women’s Brain Health, the Milken Institute’s Women’s Health Network, and the WHAM Research Collaborative to drive forward the national and international agenda on women’s health research. In recognition of her work, Dr. Jacobs was named a Robert Wood Johnson Foundation “Health and Society” Scholar, a National Institutes of Health Women's Health Fellow, and a National Academy of Sciences Frontiers of Science Fellow. Science News named her one of the “Top 10 Scientists” to watch worldwide.

  • Dr. Devi is a nationally recognized expert in the diagnosis and management of cognitive disorders related to menopause and aging. She is Founder and Director of Park Avenue Neurology, a premier center dedicated to neurologic wellness, education, and research in New York City. She is a Clinical Professor of Neurology and Psychiatry at Zucker School of Medicine and an Attending Physician at Lenox Hill Hospital. Previously, she was an Assistant Professor of Neurology at Columbia University and a Clinical Associate Professor of Neurology at NYU. A frequent presenter at national and international conferences, her current research focus is on neuro-modulation in treating stroke, dementia, and chronic pain. Her spectrum approach to dementia was featured in the New England Journal of Medicine. An author of seminal books about brain health, including “Spectrum of Hope,” “A Calm Brain,” and “Estrogen, Memory and Menopause,” Dr. Devi has been featured in various media including the BBC, CBS, the New York Times, NPR, TIME, and the Wall Street Journal.

Advisory Council

  • Hannah Linkenhoker is a trusted philanthropy and political advisor in the entertainment industry. Currently serving as Chief Engagement Officer at JSSK, the world’s preeminent media and entertainment law firm, Hannah advises celebrity clients on philanthropy, policy, and politics. She is an architect of the Menopause and Midlife Women’s Health Act, a landmark federal bill designed to close the gap in menopause research funding and attention for midlife women’s health. Her deep expertise in the U.S. health policy landscape has made her a sought-after strategist on issues ranging from maternal mortality to menopause equity. Beyond her policy work, Hannah is a civic leader and movement builder. She is a board member of Planned Parenthood Los Angeles and cofounder of the LA Women’s Collective PAC, which empowers women to drive change through political giving and leadership.

  • Alex Taylor is the co-founder of Perelel, a leading women’s health company offering OB/GYN-founded, stage-specific nutritional support for every phase of hormonal life—from menarche through perimenopause. A brand builder and advocate, Alex has helped drive Perelel’s rapid growth and national recognition.  In addition to founding Perelel, Alex is a passionate advocate for closing the women’s health research gap. She worked with the White House Gender Policy Council to support President Biden’s Executive Order on Advancing Women’s Health Research and Innovation and now helps lead cross-sector efforts to increase funding and prioritize women’s health nationally.

Anne Fulenwider

Colleen Foster

  • Anne Fulenwider is Co-Founder and Co-CEO of Alloy Women's Health, a former magazine editor, and a believer in the power of storytelling. She began her career at the literary magazine The Paris Review, spent ten years at Vanity Fair editing such writers as Carl Bernstein and Dominick Dunne, and, in 2012, was named editor-in-chief of Marie Claire, overseeing all content and brand extensions in the United States. After her mother died of a sudden heart attack in 2016, Fulenwider became motivated to make an impact in women’s health. Inspired by all the women she’s met who are building a better world for women by disrupting industries, she became an entrepreneur herself in 2020, joining Monica Molenaar to change the conversation around women’s post-reproductive health. She was named to the Forbes 50 Over 50 Class of 2024, proving that success and innovation have no age limit. In 2025, Women’s Health recognized her as one of 20 experts redefining longevity and healthspan for women in its first-ever Longevity List.

  • Colleen Foster is a General Partner of Amboy Street Ventures where she leads operations and partnerships and sits on the Investment Committee. With a strategic focus on women's health and sexual health investment, her role as General Partner at Amboy Street Ventures harnesses her expertise and relationships in corporate finance and capital markets. Colleen is a former Goldman Sachs Partner where she led the $1 billion global commodities franchise and served on the Client Business Standards Committee. Colleen has spent more than 10 years on the Board of Directors at Planned Parenthood and currently serves on the Board of Directors at the NAACP Legal Defense and Educational Fund, applying her financial insights to advance the organization's mission and to help shape policies and initiatives that foster a fair and equitable society.

Jamie Kantrowitz

Priyanka Jain

  • Jamie Kantrowitz is a growth-focused advisor and strategist with two decades of experience scaling ventures across media, technology, consumer brands, and civic innovation. She has built a career around mobilizing capital, forging cross-sector partnerships, and amplifying visibility for new and necessary ideas. Kantrowitz is the Co-Founder of the Los Angeles Women’s Collective, a political action committee that has mobilized thousands of women to help elect more female leaders. She serves on the board of Reproductive Freedom for All (formerly NARAL), the nation’s longest-standing advocacy organization for reproductive rights, and sits on the advisory boards of Galvanize USA, the Foundation for Women’s Health, and Oath.

  • Priyanka Jain is the co-founder & CEO of Evvy, a precision women’s health startup discovering overlooked biomarkers, starting with the vaginal microbiome. Evvy serves over 50,000 patients and has built the world’s largest dataset on the vaginal microbiome — powering groundbreaking research across infertility, preterm birth, gynecological cancers, and more. Priyanka serves on advisory boards for the XPRIZE Foundation and the United Nations Foundation’s Girl Up campaign. She received her B.S. from Stanford University and has been recognized as one of Forbes 30 under 30, Inc’s Top Female Founders, and Goldman Sachs’ Most Exceptional Entrepreneurs.

Alex Taylor

Hannah Linkenhoker

Interested in
learning more?

Join our mailing list